Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Rui Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Virus Latency, Epigenesis, Genetic, Virus Activation. Die Arbeit nennt 82 Literaturangaben. Gefördert von: NCI NIH HHS, National Institute of Allergy and Infectious Diseases, NIDCR NIH HHS.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) establishes lifelong latency in humans, yet sporadically reactivates into a productive lytic cycle that enables viral propagation. The lytic phase is critical for sustaining life‐long persistence and also contributes to oncogenesis by fostering cellular environments that support EBV‐associated malignancies. EBV lytic reactivation has long been understood as a complex process shaped by the integration of multiple, largely host‐derived signals. Recent advances in genome‐wide CRISPR screening, single‐cell transcriptomics, and integrative multi‐omic analyses have substantially expanded this framework, adding rich and unexpected molecular detail to how epigenetic repression, transcriptional control, metabolic adaptation, and immune–microenvironmental cues converge to regulate the latent–lytic transition. This review synthesizes recent discoveries that refine our understanding of the molecular logic of EBV reactivation and discusses how these insights are shaping new therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
- Department of Medicine, Division of Infectious Diseases, Mass General Brigham Hospital, Boston, Massachusetts, USA.
- Center for Integrated Solutions in Infectious Disease, Broad Institute, Cambridge, Massachusetts, USA.
- Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Cancer Institute
Zitieren
APA
Guo, R., & Gewurz, B. E. (2026). Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch. Journal of Medical Virology. https://doi.org/10.1002/jmv.71031
Vancouver
Guo R, Gewurz BE. Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch. Journal of Medical Virology. 2026. doi:10.1002/jmv.71031
BibTeX
@article{Guo2026,
author = {Guo, Rui and Gewurz, Benjamin E},
title = {Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71031}
}
EUVIMED